Funding for this research was provided by:
China Postdoctoral Science Foundation (2020M673648)
Chongqing Postdoctoral Science Foundation (N/V)
Natural Science Foundation of Chongqing (cstc2020jcyj-msxmX0440)
National Natural Science Foundation of China (81830062)
Article History
Received: 4 February 2023
Revised: 14 March 2023
Accepted: 19 March 2023
First Online: 10 May 2023
Competing interests
: Hongming Miao is the editorial board member of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling. All authors declare that they have no conflict of interest.